Indo US Bio-Tech Ltd.
NSE: INDOUS | BSE: 541304
₹85.82
₹-1.54
(-1.76%)
As on 21-Jul-2026 15:40IST
Market cap
₹174 Cr
Revenue (TTM)
₹110 Cr
P/E Ratio
13.2
P/B Ratio
1.9
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹13 Cr
-
ROE
23 %
-
ROCE
21.1 %
-
Industry P/E
13.48
-
EV/EBITDA
12
-
Debt to Equity
0
-
Book Value
₹46.1
-
EPS
₹6.5
-
Face value
10
-
Shares outstanding
20,052,000
10 Years Aggregate
CFO
₹-7.18 Cr
EBITDA
₹63.06 Cr
Net Profit
₹48.55 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Indo Us Bio-Tech
| -29.4 | -5.9 | -19.6 | -55.1 | -- | -- | -- |
|
BSE FMCG
| -9.4 | -0.8 | -0.4 | -12.3 | -2.2 | 6.1 | 7.8 |
|
Company
|
2025
|
|---|---|
|
Indo Us Bio-Tech
| -59.4 |
|
BSE Small Cap
| -6.6 |
|
BSE FMCG
| -2.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Indo Us Bio-Tech
|
85.8 | 173.9 | 110.4 | 13.1 | 14.6 | 14.6 | 13.2 | 1.9 |
| 186.1 | 2,004.8 | 2,001.7 | 60.8 | -- | 17.6 | 19.4 | 1.5 | |
| 278.9 | 1,387.3 | 1,439.6 | 114.8 | 10.6 | 14.4 | 12.1 | 1.7 | |
| 91.4 | 1,879.8 | 1,769.2 | 76.0 | 4.9 | 13.9 | 25.3 | 3.1 | |
| 231.8 | 283.0 | 646.2 | 31.9 | 3.4 | 17.6 | 9.8 | 1.6 | |
| 867.5 | 4,453.3 | 1,394.8 | 295.8 | 19.8 | 16.7 | 15.1 | 2.5 | |
| 3.7 | 400.9 | 1,139.6 | 259.7 | 23.1 | 21 | 1.5 | 0.3 | |
| 164.9 | 313.5 | 445.1 | 41.6 | 10.9 | 5.6 | 7.5 | 0.5 | |
| 285.0 | 316.4 | 17.8 | 0.3 | 1.6 | 4.7 | 1058 | 45.7 | |
| 3.5 | 434.8 | 1,345.6 | 31.8 | 4.8 | 6.8 | 13.7 | 0.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Indo Us Bio-Tech
Manufacture of food products
-
Incorporated
2004
-
Chairman
--
-
Managing Director
Jagdish Ajudia
-
Headquarters
Ahmedabad, Gujarat
-
Website
Looking for more details about Indo US Bio-Tech Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Indo Us Bio-Tech
What is the current share price of Indo US Bio-Tech Ltd Today?
The share price of Indo US Bio-Tech Ltd is ₹85.82 (NSE) and ₹86.50 (BSE) as of 21-Jul-2026 15:40 IST. Indo US Bio-Tech Ltd has given a return of -55.07% in the last 1 years.
What is the current PB & PE ratio of Indo US Bio-Tech Ltd?
The P/E ratio of Indo US Bio-Tech Ltd is 13.25 times as on 21-Jul-2026, a 2 discount to its peers’ median range of 13.48 times.
The P/B ratio of Indo US Bio-Tech Ltd is 1.88 times as on 21-Jul-2026, a 15 premium to its peers’ median range of 1.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
18.15
|
3.76
|
|
2024
|
53.94
|
7.09
|
|
2023
|
14.71
|
3.91
|
|
2022
|
12.22
|
1.61
|
|
2021
|
3.36
|
0.93
|
What is the 52 Week High and Low of Indo US Bio-Tech Ltd?
The 52-week high and low of Indo US Bio-Tech Ltd are Rs 206.00 and Rs 84.91 as of 21-Jul-2026.
What is the market cap of Indo US Bio-Tech Ltd?
Indo US Bio-Tech Ltd has a market capitalisation of ₹ 174 Cr as on 21-Jul-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Indo US Bio-Tech Ltd?
Before investing in Indo US Bio-Tech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.